2020plus

2020plus classifies genes as oncogenes, tumor suppressor genes, or non-driver genes using small somatic variant data and a Random Forest machine learning framework.


Key Features:

  • Random Forest Classification: Applies a Random Forest ensemble learning algorithm to analyze somatic mutation data for driver gene prediction.
  • Ratiometric Machine Learning Approach: Uses a machine-learning-based ratiometric strategy to improve classification accuracy of cancer driver genes.
  • Driver Gene Categorization: Distinguishes oncogenes, tumor suppressor genes, and non-driver genes based on patterns of small somatic variants.
  • Performance Evaluation Framework: Operates within a benchmarking framework that evaluates driver gene prediction methods and compares multiple computational approaches.
  • Mutation Rate Variability Analysis: Examines the impact of unexplained variability in mutation rates on false-positive driver gene predictions.

Scientific Applications:

  • Cancer Genomics: Supports identification and classification of cancer driver genes involved in tumorigenesis.
  • Somatic Mutation Analysis: Enables analysis of somatic mutation datasets to evaluate gene roles in cancer development.
  • Method Evaluation in Driver Gene Prediction: Facilitates comparison and benchmarking of computational approaches for cancer driver gene identification.

Methodology:

The tool applies a Random Forest machine learning model with a ratiometric feature-based approach to analyze somatic mutation data and classify genes into oncogenes, tumor suppressor genes, or non-driver genes while evaluating prediction performance across computational methods.

Topics

Details

License:
Apache-2.0
Maturity:
Mature
Cost:
Free of charge
Tool Type:
command-line tool, workflow
Operating Systems:
Linux
Programming Languages:
Python
Added:
2/8/2019
Last Updated:
11/25/2024

Operations

Data Inputs & Outputs

Expression profile clustering

Publications

Tokheim CJ, Papadopoulos N, Kinzler KW, Vogelstein B, Karchin R. Evaluating the evaluation of cancer driver genes. Proceedings of the National Academy of Sciences. 2016;113(50):14330-14335. doi:10.1073/pnas.1616440113. PMID:27911828. PMCID:PMC5167163.

PMID: 27911828
PMCID: PMC5167163
Funding: - HHS | NIH | National Cancer Institute: 1U24CA204817-01, 5U01CA180956-03, F31CA200266, P50-CA62924

Documentation

Downloads